Lead Paragraph
Researchers at the UNC School of Medicine have identified a mechanism that may explain why some plant foods aggravate symptoms in certain people with inflammatory bowel disease (IBD). Their study, published in Cellular and Molecular Gastroenterology and Hepatology, found that patients with Crohn’s disease and ulcerative colitis often have reduced levels of transporter proteins needed to move oxalate, a compound found in spinach, almonds, and other plant foods, through the intestine.
Background Context
Diet has long been recognised as an important factor in managing IBD, though the relationship between specific foods and gut inflammation remains complex. Plant-based diets are generally encouraged for their fibre content and broader health benefits, and previous research summarised in The Lancet has associated higher plant food intake with fewer hospitalisations and surgical interventions among IBD patients. However, clinicians have long observed that individual patients respond differently to the same dietary patterns, and oxalate, a naturally occurring compound in many otherwise healthy foods, has not previously been closely examined as a contributing factor in IBD specifically.
Key Findings
According to the UNC research team, people with Crohn’s disease and ulcerative colitis frequently show lower levels of specific transporter proteins responsible for moving oxalate across the intestinal lining. When this transport system is impaired, the researchers found that oxalate can build up within the gut rather than being processed and cleared normally. The study authors reported that this accumulation may amplify existing intestinal inflammation in affected patients. Importantly, the researchers were clear that this finding does not indicate plant foods should be eliminated from the diet. Fibre-rich, plant-based foods remain a valuable source of nutrients, and the researchers stressed that further studies are needed before any changes to dietary guidance are considered. The authors describe the work as an early but meaningful step towards understanding why dietary responses vary so widely between individual IBD patients, rather than a basis for immediate changes to clinical or dietary recommendations.
Clinical Relevance
For gastroenterologists, IBD nurses, and dietitians, this research adds a biological explanation for a pattern many clinicians already observe: that some patients react unpredictably to foods generally considered beneficial. The findings reinforce the case for individualised dietary assessment within IBD care, rather than applying blanket plant-based recommendations to all patients. For those living with Crohn’s disease or ulcerative colitis, the study is a reminder that dietary tolerance can vary significantly between individuals, and that any dietary changes, particularly involving high-oxalate foods, should be discussed with a gastroenterologist or dietitian rather than adjusted independently. The authors are clear that this is preliminary evidence, not a signal to restrict plant food intake, and that larger studies are required before this mechanism informs formal dietary guidance.
Reference
UNC School of Medicine. Oxalate transport and intestinal inflammation in inflammatory bowel disease. Cellular and Molecular Gastroenterology and Hepatology. Full citation details (volume, issue, page numbers, and DOI) were not specified in the available source material.
This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.